Compare ALKS & IAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALKS | IAG |
|---|---|---|
| Founded | 1987 | 1990 |
| Country | Ireland | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7B | 9.5B |
| IPO Year | 2012 | 2002 |
| Metric | ALKS | IAG |
|---|---|---|
| Price | $52.20 | $14.59 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 4 |
| Target Price | ★ $43.43 | $17.75 |
| AVG Volume (30 Days) | 2.3M | ★ 4.6M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,475,899,000.00 | N/A |
| Revenue This Year | $24.26 | $44.70 |
| Revenue Next Year | $4.47 | $1.11 |
| P/E Ratio | ★ N/A | $18.66 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $25.17 | $6.69 |
| 52 Week High | $55.67 | $24.87 |
| Indicator | ALKS | IAG |
|---|---|---|
| Relative Strength Index (RSI) | 56.70 | 39.14 |
| Support Level | $27.78 | $12.52 |
| Resistance Level | $55.67 | $14.66 |
| Average True Range (ATR) | 1.70 | 0.58 |
| MACD | -0.67 | -0.12 |
| Stochastic Oscillator | 19.18 | 20.18 |
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Iamgold Corp is a mid-tier gold mining company. The company operating gold mines are divided into geographic segments such as Cote Gold mine - Canada, Burkina Faso - Essakane mine, Westwood mine - Canada. The company's s non-gold mine segments are Exploration and evaluation and development, and Corporate - which includes royalty interests. The company generates the majority of its revenue from the Cote Gold mine segment.